IgGenix

IgGenix Pronounces Transfer of Headquarters to Lilly Gateway Labs in South San Francisco

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–IgGenix, Inc., a biotechnology company taking a revolutionary approach to directly alleviate allergic disease, announced today…

Read More »